Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest. 2005 Aug; 115(8):2149-58.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.